Why the study?
Can peripheral blood PIP serve as a useful marker of myocardial fibrosis in patients with heart failure of hypertensive origin?
Can peripheral blood PIP serve as a useful marker of myocardial fibrosis in patients with heart failure of hypertensive origin?
Peripheral blood PIP may serve as a useful non-invasive biomarker for detecting myocardial fibrosis in patients with hypertensive heart disease and heart failure.
No takes yet. Share an insight, caveat, or question.
Peripheral PIP may mark myocardial fibrosis in hypertensive heart disease; leaves open prospective validation as non-invasive biomarker in HF.
Querejeta et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: